Engineering light-sensitive channels to control brain activity
Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition
This study is working on new tools that use light to help control brain activity, which could lead to better treatments for conditions like epilepsy by allowing scientists to understand how the brain works more clearly.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10677649 on NIH RePORTER |
What this research studies
This research focuses on developing advanced optogenetic tools that use light to precisely control neuronal activity in the brain. By engineering natural light-gated chloride channels, the project aims to create more effective inhibitory tools that can silence neurons with high sensitivity and speed. This approach could enhance our understanding of brain functions and provide new treatment options for neurological disorders, particularly epilepsy. The methodology involves testing these channels in mammalian cells to evaluate their effectiveness in modulating neural activity.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with epilepsy or seizure disorders who may benefit from innovative treatment options targeting neural activity.
Not a fit: Patients with non-neurological conditions or those who do not experience seizures may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for epilepsy and other neurological disorders by providing a more effective way to inhibit abnormal brain activity.
How similar studies have performed: Other research has shown promise in using optogenetic approaches for neural modulation, but the specific use of light-gated chloride channels represents a novel and potentially groundbreaking advancement.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Xue, Mingshan — Baylor College of Medicine
- Study coordinator: Xue, Mingshan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.